SCHEMBL4855728

SCHEMBL4855728

CC(C)(C)C1CCC(c2ccccc2N2CCN(CC(=O)N3CCCCC3)CC2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.53
KDM4E B2RXH2 3/20 0.53
TDP1 Q9NUW8 2/20 0.53
MAPT P10636 3/20 0.45
CHRM2 P08172 4/20 0.44
CHRM4 P08173 4/20 0.44
CHRM1 P11229 4/20 0.44
CHRM3 P20309 3/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
TSHR P16473 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
GFER P55789 2/20 0.44
GAA P10253 3/20 0.43
HTR1A P08908 1/20 0.43
ADRA1B P35368 1/20 0.43
RBP4 P02753 1/20 0.41
TERT O14746 1/20 0.40
PKM P14618 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4849565 0.99 ALDH1A1 (0.52) ALDH1A1KDM4ETDP1MAPTCHRM2
Hydrochloric Acid SCHEMBL4855745 0.99 ALDH1A1 (0.52) ALDH1A1KDM4ETDP1MAPTCHRM2
Hydrochloric Acid SCHEMBL4858553 0.99 ALDH1A1 (0.52) ALDH1A1KDM4ETDP1MAPTCHRM2
Hydrochloric Acid SCHEMBL4851175 0.98 ALDH1A1 (0.53) ALDH1A1KDM4ETDP1MAPTCHRM2
Hydrochloric Acid SCHEMBL4858345 0.89 MAPT (0.47) ALDH1A1KDM4ETDP1MAPTKMT2A
Hydrochloric Acid SCHEMBL4852481 0.87 HTR1A (0.43) ALDH1A1KDM4ETDP1MAPTCHRM2
Hydrochloric Acid SCHEMBL4857486 0.83 HTR1A (0.43) ALDH1A1KDM4ETDP1MAPTKMT2A
SCHEMBL4854496 0.83 ALDH1A1 (0.52) ALDH1A1KDM4EMAPTKMT2AMEN1
Hydrochloric Acid SCHEMBL4848295 0.82 HTR1A (0.46) ALDH1A1KDM4EMAPTCHRM3GAA
Hydrochloric Acid SCHEMBL4858027 0.82 HTR1A (0.42) ALDH1A1KDM4ETDP1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1698620-B1 BENZENE COMPOUNDS DISUBSTITUTED WITH CYCLIC GROUPS AT THE 1- AND 2-POSITIONS EISAI R&D MAN CO LTD (JP) 2016-09-28 EP disclosed
EP-1698620-B1 BENZENE COMPOUNDS DISUBSTITUTED WITH CYCLIC GROUPS AT THE 1- AND 2-POSITIONS EISAI R&D MAN CO LTD (JP) 2016-09-28 EP disclosed
US-7425554-B2 1,2-di(cyclic)substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-09-16 US disclosed
US-7425554-B2 1,2-di(cyclic)substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-09-16 US disclosed
US-7425554-B2 1,2-di(cyclic)substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-09-16 US disclosed
US-7410971-B2 1,2-di(cyclic)substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-08-12 US disclosed
US-7410971-B2 1,2-di(cyclic)substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-08-12 US disclosed
US-7410971-B2 1,2-di(cyclic)substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-08-12 US disclosed
US-20070112002-A1 1,2-di(cyclic)substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-05-17 US disclosed
US-20070112002-A1 1,2-di(cyclic)substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-05-17 US disclosed
US-20070112002-A1 1,2-di(cyclic)substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-05-17 US disclosed
US-20060276465-A1 1,2-di(cyclic) substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2006-12-07 US disclosed
EP-1698620-A1 BENZENE COMPOUNDS DISUBSTITUTED WITH CYCLIC GROUPS AT THE 1- AND 2-POSITIONS Eisai Co., Ltd. (JP) 2006-09-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112002-A1 1,2-di(cyclic)substituted benzene compounds CCR10, HRH3, HRH1 ALDH1A1 707/4885KDM4E 3710/4885TDP1 3111/4885
US-20060276465-A1 1,2-di(cyclic) substituted benzene compounds HRH3, CCR10, HRH1 ALDH1A1 617/4885KDM4E 3905/4885TDP1 2830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.